X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
female (51) 51
male (51) 51
adult (46) 46
infectious diseases (42) 42
middle aged (40) 40
index medicus (37) 37
hiv (36) 36
immunology (28) 28
hiv infections - drug therapy (26) 26
virology (25) 25
hiv infections - immunology (24) 24
aids (23) 23
cd4 lymphocyte count (17) 17
antiretroviral therapy, highly active (16) 16
aged (15) 15
antiretroviral therapy (15) 15
viral load (15) 15
infection (14) 14
human immunodeficiency virus--hiv (13) 13
hiv infection (12) 12
antiretroviral drugs (11) 11
antiviral agents (11) 11
hiv infections - virology (11) 11
microbiology (11) 11
retrospective studies (11) 11
risk factors (11) 11
analysis (10) 10
anti-hiv agents - therapeutic use (10) 10
highly active antiretroviral therapy (10) 10
active antiretroviral therapy (9) 9
aids/hiv (9) 9
cd4-positive t-lymphocytes - immunology (8) 8
drug therapy (8) 8
flow cytometry (8) 8
hiv-1 (8) 8
lymphocytes (8) 8
pharmacology & pharmacy (8) 8
prospective studies (8) 8
adolescent (7) 7
cohort studies (7) 7
disease (7) 7
drug therapy, combination (7) 7
epidemiology (7) 7
hiv infections - epidemiology (7) 7
hiv patients (7) 7
individuals (7) 7
infections (7) 7
italy (7) 7
multidisciplinary sciences (7) 7
treatment interruption (7) 7
treatment outcome (7) 7
acquired immune deficiency syndrome--aids (6) 6
aged, 80 and over (6) 6
antiviral agents - therapeutic use (6) 6
apoptosis (6) 6
cd8-positive t-lymphocytes - immunology (6) 6
gastroenterology & hepatology (6) 6
genotype (6) 6
haart (6) 6
hiv infections - complications (6) 6
human immunodeficiency virus (6) 6
human-immunodeficiency-virus (6) 6
incidence (6) 6
italy - epidemiology (6) 6
medical research (6) 6
medicine & public health (6) 6
medicine, experimental (6) 6
mortality (6) 6
patients (6) 6
prevalence (6) 6
research article (6) 6
time factors (6) 6
young adult (6) 6
acquired immune deficiency syndrome (5) 5
anti-hiv agents - administration & dosage (5) 5
care and treatment (5) 5
cd4 antigen (5) 5
drug administration schedule (5) 5
expression (5) 5
health aspects (5) 5
hepatitis c (5) 5
hiv infections - pathology (5) 5
hiv-1 - genetics (5) 5
hiv-1-infected patients (5) 5
hiv-infection (5) 5
medicine (5) 5
risk (5) 5
safety (5) 5
science (5) 5
therapy (5) 5
viruses (5) 5
acquired immunodeficiency syndrome - drug therapy (4) 4
acquired immunodeficiency syndrome - immunology (4) 4
activation (4) 4
anti-retroviral agents - therapeutic use (4) 4
antiretrovirals (4) 4
biomarkers (4) 4
cd4 (4) 4
cd4-cd8 ratio (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific reports, ISSN 2045-2322, 01/2019, Volume 9, Issue 1, pp. 585 - 8
We reported the efficacy and safety data for daclatasvir (DCV)-based all-oral antiviral therapy in patients treated in the Italian compassionate-use program.... 
SUSTAINED VIROLOGICAL RESPONSE | EFFICACY | PLUS SOFOSBUVIR | SAFETY | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | VIRUS GENOTYPE 3 | INFECTION | RIBAVIRIN | ADVANCED LIVER-DISEASE
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2018, Volume 13, Issue 2, p. e0192627
The renal function is a key-issue in HIV/HCV co-infected patients, nevertheless, it has not established so far whether HCV treatment with new direct acting... 
SUSTAINED VIROLOGICAL RESPONSE | VIRUS-INFECTION | MULTIDISCIPLINARY SCIENCES | TREATMENT-EXPERIENCED PATIENTS | CLINICAL-PRACTICE GUIDELINE | GENOTYPE 1 INFECTION | DIRECT-ACTING ANTIVIRALS | OPEN-LABEL | CHRONIC KIDNEY-DISEASE | HEPATITIS-C | TREATMENT-NAIVE PATIENTS | Glomerular Filtration Rate | Hepatitis C - drug therapy | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Humans | Middle Aged | Male | Antiviral Agents - administration & dosage | Uracil - administration & dosage | Ribavirin - administration & dosage | HIV Infections - complications | Female | HIV Infections - drug therapy | Hepatitis C - complications | Macrocyclic Compounds - administration & dosage | Drug Therapy, Combination | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Measurement | Antiviral agents | Comorbidity | Patient outcomes | Drug therapy | Hepatitis C | Observations | HIV infection | Glomerular filtration rate | Slopes | Health sciences | Renal function | Ritonavir | Liver | Infections | Ribavirin | Tropical diseases | Tenofovir | Hepatitis | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Aging | Stiffness | Public health | Genotypes | Creatinine | Integrase | Statistical analysis | Filtration | Epidermal growth factor receptors | Cut-off | Ribonucleic acid--RNA | Patients | Medicine | Infectious diseases | Hospitals | Kidney diseases | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
by Bertoli, Ada and Sorbo, Maria Chiara and Aragri, Marianna and Lenci, Ilaria and Teti, Elisabetta and Polilli, Ennio and Di Maio, Velia Chiara and Gianserra, Laura and Biliotti, Elisa and Masetti, Chiara and Magni, Carlo F and Babudieri, Sergio and Nicolini, Laura A and Milana, Martina and Cacciatore, Pierluigi and Sarmati, Loredana and Pellicelli, Adriano and Paolucci, Stefania and Craxì, Antonio and Morisco, Filomena and Palitti, Valeria Pace and Siciliano, Massimo and Coppola, Nicola and Iapadre, Nerio and Puoti, Massimo and Rizzardini, Giuliano and Taliani, Gloria and Pasquazzi, Caterina and Andreoni, Massimo and Parruti, Giustino and Angelico, Mario and Perno, Carlo Federico and Cento, Valeria and Ceccherini-Silberstein, Francesca and Andreone, Pietro and Baldanti, Fausto and Barbarini, Giorgio and Boccaccio, Vincenzo and Boglione, Lucio and Bolis, Matteo and Bonora, Stefano and Borghi, Vanni and Brancaccio, Giuseppina and Bruno, Savino and Bruzzone, Bianca and Calvaruso, Vincenza and Caporaso, Nicola and Ciaccio, Antonio and Ciancio, Alessia and Colombatto, Piero and Cozzolongo, Raffaele and D'Ambrosio, Cecilia and D'Ettorre, Gabriella and De Leonardis, Francesco and De Luca, Andrea and Di Biagio, Antonio and Di Perri, Giovanni and Francioso, Simona and Gaeta, Giovanni Battista and Gasbarrini, Antonio and Ghisetti, Valeria and Giorgini, Alessia and Grieco, Antonio and Gubertini, Guido and Gulminetti, Roberto and Lambiase, Lara and Landonio, Simona and Lichtner, Miriam and Maida, Ivana and Marenco, Simona and Marinaro, Letizia and Maserati, Renato and Melis, Michela and Menzaghi, Barbara and Meregalli, Elisa and Micheli, Valeria and Niero, Fosca and Paoloni, Maurizio and Pieri, Alessandro and Rendina, Maria and Romagnoli, Dante and Rossetti, Barbara and Ruggiero, Tina and Sangiovanni, Vincenzo and Starace, Mario and Sticchi, Laura and Tarquini, Pierluigi and Toniutto, Pierluigi and Vullo, Vincenzo and Zazzi, Maurizio and Hcv Virology Italian Resistance Ne and HCV Virology Italian Resistance Network (VIRONET-C)
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 8988 - 11
Natural resistance-associated substitutions (RASs) are reported with highly variable prevalence across different HCV genotypes (GTs). Frequency of natural RASs... 
GLECAPREVIR | TREATMENT-NAIVE | REAL-LIFE | PIBRENTASVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | SIMEPREVIR PLUS SOFOSBUVIR | RESPONSE RATES | DIRECT-ACTING ANTIVIRALS | 1 INFECTION | OPEN-LABEL | Hepatitis C | Disease resistance | Genotypes
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e50728
Objective: Immune changes occurring after primary HIV infection (PHI) have a pivotal relevance. Our objective was to characterize the polyfunctionality of... 
RESPONSES | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | GASTROINTESTINAL-TRACT | IMMUNE ACTIVATION | TREATMENT INTERRUPTION | PERIPHERAL-BLOOD | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 INFECTION | FUNCTIONAL PROFILE | LYMPHOCYTES | HIV Infections - virology | Humans | Middle Aged | Male | Viral Load | Antiretroviral Therapy, Highly Active | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV-1 - immunology | Lymphocyte Activation - immunology | CD8-Positive T-Lymphocytes - virology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | CD4-Positive T-Lymphocytes - virology | CD8-Positive T-Lymphocytes - immunology | Longitudinal Studies | Medical research | Medicine, Experimental | Development and progression | HIV (Viruses) | T cells | Health aspects | HIV infection | Flow cytometry | Antiretroviral drugs | Therapy | Immune response | Peptides | Immunoregulation | CD8 antigen | Activation | Lymphocytes T | Infections | Patients | CD4 antigen | Cytometry | Cell activation | Nef protein | Interleukin 2 | Acquired immune deficiency syndrome--AIDS | Lymphocytes | CD38 antigen | Human immunodeficiency virus--HIV | Histocompatibility antigen HLA | Predictive control | Apoptosis | Immune system | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Antiviral Research, ISSN 0166-3542, 12/2019, Volume 172, p. 104635
The accumulation of drug-resistance mutations on combined antiretroviral regimens (ART) backbone could affect the virological efficacy of the regimen. Our aim... 
Genotypic resistance test | M184V/I | Drug resistance | NNRTIs | Dolutegravir
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 11/2008, Volume 49, Issue 3, pp. 282 - 286
OBJECTIVES:The objectives of this study are to describe trends over time from 1992 to 2006 in the number of newly diagnosed HIV-infected individuals in Modena... 
AIDS presenters | Late tester | Epidemiology | epidemiology | DIAGNOSIS | INFECTIOUS DISEASES | CD4 CELL COUNTS | ACTIVE ANTIRETROVIRAL THERAPY | AIDS | INFECTION | IMMUNOLOGY | late tester | Multivariate Analysis | HIV Infections - epidemiology | Humans | Middle Aged | Risk Factors | Male | CD4 Lymphocyte Count | HIV Infections - immunology | Time Factors | HIV Infections - diagnosis | Adult | Female | Italy
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3704 - 3704
Abstract Introduction:Potent antiretroviral drugs block the progression of HIV infection and inhibit virus integration into the host DNA. Response to therapy... 
Journal Article